Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
Carraro S, di Palmo E, Licari A, Barni S, Caldarelli V, De Castro G, Di Marco A, Fenu G, Giordano G, Lombardi E, Pirillo P, Stocchero M, Volpini A, Zanconato S, Rusconi F; Italian Paediatric Severe Asthma Network (IPSAN).
Carraro S, et al. Among authors: di marco a, di palmo e.
Allergy. 2022 May 23;77(9):2852-6. doi: 10.1111/all.15385. Online ahead of print.
Allergy. 2022.
PMID: 35603478
Free PMC article.
No abstract available.